The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up
Figure 3
Kaplan-Meier curve and pointwise confidence intervals for disease-free/failure-free survival (): 16 (70%) distant or local regional failures or deaths; median (95% CI) FFS = 19.9 (7.7, 78.0) months.